ABALOS Trademark

Trademark Overview


On Monday, July 27, 2020, a trademark application was filed for ABALOS with the United States Patent and Trademark Office. The USPTO has given the ABALOS trademark a serial number of 90075873. The federal status of this trademark filing is REGISTERED as of Tuesday, June 14, 2022. This trademark is owned by Abalos Therapeutics GmbH. The ABALOS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical, medical and veterinary preparations for use in treating cancer; pharmaceutical, medical and veterinary preparations containing arenaviruses for use in treating cancer; pharmaceutical, medical and veterinary preparations containing a lymphocytic choriomeningitis virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing an Ippy virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing a Lassa virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing a Mobala virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing a Mopeia virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing an Allpaahuayo virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing an Amapari virus for use in treating cancer; pharmaceutical, medical and veterinary prepara...
abalos

General Information


Serial Number90075873
Word MarkABALOS
Filing DateMonday, July 27, 2020
Status700 - REGISTERED
Status DateTuesday, June 14, 2022
Registration Number6756581
Registration DateTuesday, June 14, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 29, 2022

Trademark Statements


Goods and ServicesPharmaceutical, medical and veterinary preparations for use in treating cancer; pharmaceutical, medical and veterinary preparations containing arenaviruses for use in treating cancer; pharmaceutical, medical and veterinary preparations containing a lymphocytic choriomeningitis virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing an Ippy virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing a Lassa virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing a Mobala virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing a Mopeia virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing an Allpaahuayo virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing an Amapari virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing a Bear Canyon virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing a Chapare virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing a Cupixi virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing a Flexal virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing a Guanarito virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing a Junin virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing a Latino virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing a Machupo virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing an Oliveros virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing a Parana virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing an Pichinde virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing an Pirital virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing a Sabia virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing a Tacaribe virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing a Tamiami virus for use in treating cancer; pharmaceutical, medical and veterinary preparations containing a Whitewara Arroyo virus for use in treating cancer; cancer drugs, namely, pharmaceutical preparations for use in treating cancer; immuno-oncology drugs, namely, pharmaceutical preparations for use in treating cancer; vaccines
Translation of Words in MarkThe English translation of "ABALOS" in the mark is "shock", "shaking", or "tremor".

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 25, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAbalos Therapeutics GmbH
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressDuesseldorf 40225
DE

Party NameAbalos Therapeutics GmbH
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressDuesseldorf 40225
DE

Party NameAbalos Therapeutics GmbH
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressEssen 45130
DE

Trademark Events


Event DateEvent Description
Tuesday, June 14, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 14, 2022REGISTERED-PRINCIPAL REGISTER
Thursday, April 28, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, April 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 28, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 29, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 29, 2022PUBLISHED FOR OPPOSITION
Wednesday, March 9, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, February 19, 2022LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, February 18, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 21, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 20, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 20, 2022TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, July 30, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, July 30, 2021FINAL REFUSAL E-MAILED
Friday, July 30, 2021FINAL REFUSAL WRITTEN
Thursday, July 8, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 8, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 7, 2021ASSIGNED TO LIE
Tuesday, May 18, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 19, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 19, 2020NON-FINAL ACTION E-MAILED
Thursday, November 19, 2020NON-FINAL ACTION WRITTEN
Thursday, November 12, 2020ASSIGNED TO EXAMINER
Tuesday, August 25, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, July 30, 2020NEW APPLICATION ENTERED IN TRAM